Rockets and Duds: Week 15 - March 31, 2025
5i Research Weekly Rockets and Duds This week's 5i Research Rockets and...
New Issues
While it is easy to abandon an asset class with a mention of the dreaded word “bubble” or such drawdowns, we think there is a lot...
Bonds have seen dormant popularity over the past decade and with rising rates, bonds are becoming even less attractive. Equities, on the other...
Since the beginning of 2022, there has been an uninterrupted sequence of bad news. The current headlines are all about the three Rs: recession,...
Check out the refreshed website and new features!
Neighbourly Pharmacy (NBLY) chain, Canada’s third-largest pharmacy chain operator, has filed preliminary documents for a $150 million...
About four months into the year, if we were forced to pronounce an investment ‘theme’ for 2021, it would probably be that of...
One of the stocks that our company follows got attacked this week. That’s right, Well Technologies (WELL on TSX) was the subject of not one,...
Looking for more? Sign up for a FREE 14 day trial! No credit card required
We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!
More from 5i Research
5 from 5i: Best Investments to Own During a Recession
Weekly stock market update & five stock related articles we thought were a must-read this...
Canadian Stock Outliers: EBIT Growth and Return On Capital
In this edition of ‘Stock Teasers’, we are going to be looking at Canadian stock...